RECALL RECORD — CLASS IIRecall closedF-0409-2018/FDA enforcement

Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle

What you need to know

Class II
  • What happened

    The label does not list "Sodium" in the ingredient statement.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Stop taking the supplement. Check the lot and UPC codes below, then return it to the retailer or contact the manufacturer about a refund. Seek medical advice if you have concerns about exposure.

Recall closed · classified by the FDAAL, AR, AZ, CA +36 moreMore supplements

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameReese Pharmaceutical Company
Recalling firmReese Pharmaceutical CompanyCleveland, OH, United States
UPC / barcodes
0 70038 60863 90 93351 00909 90 84579 12451 00 87701 40672 07 25439 95738 00 52569 14073 40 75450 06187 10 23513 81512 10 96295 13167 30 96295 12239 80 41310 62997 07 08820 15072 0
Lot / date codes
  • All lots
Distribution area
ALARAZCACOCTFLGAHIIAIDILINKYLAMAMDMEMIMNMOMSNCNENJNYOHOKORPASCSDTNTXUTVAWAWIWVWY

Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV & WY.

United States

Quantity affected610, 840 units/10 tablets
Recall initiationFDA report date: December 6, 2017
FDA recall numberF-0409-2018

Beyond the headline

The recall, in context

Reese Pharmaceutical Company initiated this supplements recall on August 31, 2017. The FDA enforcement report states: The label does not list "Sodium" in the ingredient statement. The FDA report lists distribution as: Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV & WY.

The FDA enforcement report describes the reason as: The label does not list "Sodium" in the ingredient statement.

Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle was made or distributed by Reese Pharmaceutical Company in Cleveland, OH, United States. This page reflects FDA report F-0409-2018, dated December 6, 2017.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Product safety recall

Symptoms to watch for

The official enforcement report describes the specific risk. Follow the recall notice, check the product codes and do not use a product that may be affected.

Higher-risk groups

Children, pregnant people, older adults and people with weakened immune systems should take extra care when a product's safety is uncertain.

What to do now

  1. 1Stop using or eating the product and keep it away from children and pets.
  2. 2Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return.
  3. 3Seek medical advice if anyone develops severe or worrying symptoms after exposure.

Read the official source record for the specific hazard and instructions.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle recall?

Reese Pharmaceutical Company recalled Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle in an FDA Class II enforcement action reported as F-0409-2018. The label does not list "Sodium" in the ingredient statement.

What should I do if I bought this product?

Stop taking the supplement. Check the lot and UPC codes below, then return it to the retailer or contact the manufacturer about a refund. Seek medical advice if you have concerns about exposure. Stop using or eating the product and keep it away from children and pets. Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return. Seek medical advice if anyone develops severe or worrying symptoms after exposure.

Is the Reese Pharmaceutical Company recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0409-2018. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Reese Pharmaceutical Company

View brand

Related alerts

Recent Other safety concern recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.